Apr 15 |
Latest Insider Selling in April 2024: 10 Stocks to Watch
|
Apr 9 |
Madrigal announces US launch of NASH/MASH drug Rezdiffra
|
Apr 9 |
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
|
Apr 5 |
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
|
Apr 4 |
Madrigal Pharmaceuticals Inc Director James Daly Sells 32,489 Shares
|
Apr 4 |
Madrigal Pharmaceuticals Inc Director Richard Levy Sells 11,000 Shares
|
Apr 4 |
Madrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
|
Apr 3 |
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Apr 3 |
1 No-Brainer Growth Stock to Buy Now
|
Apr 2 |
The 3 Best Biotech Stocks to Buy in April 2024
|